Matrix Adds Abbott and McDonald's, Exits Nestlé in Value Shift
0h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
portfolio-managementlarge-cap-value
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Matrix Asset Advisors made significant changes to its Large Cap Value portfolio for the third quarter of 2026, initiating new positions in Abbott Laboratories and McDonald's while liquidating its holding in Nestlé. The moves were disclosed in a regulatory filing on August 3, 2026, reflecting a strategic adjustment within the firm's approximately $2.5 billion portfolio. This rotation highlights a preference for US-based healthcare and consumer staples with strong domestic revenue streams over a European peer facing currency and growth headwinds.
Large-cap value managers are actively repositioning portfolios in response to persistent volatility in currency markets and shifting interest rate expectations. The US Dollar Index has strengthened 5% year-to-date against a basket of major currencies, pressuring the translated earnings of multinationals with significant European exposure. This creates a direct headwind for a company like Nestlé, which generates less than 20% of its sales in North America.
The last major portfolio shift from Matrix occurred in Q4 2025, when the firm exited ExxonMobil and added Verizon, anticipating a defensive rotation toward telecommunications. The current move extends this defensive posture but narrows the focus to companies with proven pricing power and consistent dividend growth. The catalyst for exiting Nestlé likely stems from its recent earnings miss and a downward revision to its full-year organic sales growth guidance, which fell below 5%.
Abbott Laboratories currently offers a dividend yield of 1.8%, slightly above the S&P 500's average of 1.5%. The company has increased its dividend for 52 consecutive years, qualifying it as a Dividend King. McDonald's dividend yield is more substantial at 2.3%, supported by a payout ratio of 55% of earnings.
Nestlé's dividend yield of 2.8% is higher than both new additions, but its dividend growth rate has lagged, averaging 3% annually over the past five years. Abbott's five-year dividend growth rate is 10%, while McDonald's is 8%. The table below contrasts key financial metrics from the most recent quarters.
| Metric | Abbott Labs (ABT) | McDonald's (MCD) | Nestlé (NSRGY) |
|---|---|---|---|
| Forward P/E Ratio | 24.5x | 22.1x | 18.5x |
| Revenue Growth (YoY) | +4.2% | +6.1% | +2.8% |
| Net Profit Margin | 16.5% | 33.1% | 11.2% |
Abbott's medical device segment reported sales growth of 7.5%, outperforming the broader medical products industry.
Matrix's rotation signals a vote of confidence in US consumer resilience and healthcare innovation, potentially benefiting sector peers like Medtronic and Starbucks. The exit from Nestlé may contribute to selling pressure on other European consumer staples with high US ownership, such as Unilever and Danone. Flows into defensive, high-quality US names with international revenue could tighten valuation spreads within the large-cap value universe.
A key risk to this strategy is US economic data softening more than anticipated, which would challenge the premium valuations of domestic-focused companies. The trade assumes the US economy will continue to outperform its European counterparts, a view that could be upended by a sudden shift in Federal Reserve policy. Institutional flow data indicates net buying in the healthcare sector over the past month, aligning with Matrix's new position in Abbott.
The next major catalyst for Abbott and McDonald's will be their Q3 2026 earnings reports, scheduled for October 21 and October 24, respectively. Investors will scrutinize same-store sales growth for McDonald's and procedure volume recovery metrics for Abbott's medical device division. The July US Consumer Price Index report on August 12 will be critical for assessing the sustainability of consumer spending power.
Technical levels to monitor include Abbott's 200-day moving average at $112.50, which has acted as strong support. For McDonald's, a break above the $295 resistance level would signal renewed bullish momentum. The EUR/USD exchange rate holding below 1.06 would continue to validate the thesis behind reducing European exposure. Monitor the `Vanguard Value ETF (VTV)` for broader sector sentiment shifts.
Retail investors should view this as an example of institutional risk management rather than a direct signal to trade. Portfolio adjustments by a single firm are specific to its strategy and holdings. The broader takeaway is the emphasis on strong US dollar cash flows and dividend growth, themes accessible through low-cost ETFs focused on US dividend aristocrats. This highlights the importance of understanding the underlying rationale behind major portfolio moves.
Over the long term, value investing has traditionally outperformed growth, but this relationship has been volatile. From 2007 to 2020, the Russell 1000 Growth Index significantly outpaced its value counterpart. However, value staged a strong comeback in 2022, with the Russell 1000 Value Index falling 7.5% compared to a 29% drop for the growth index. The cycle is highly dependent on interest rates and economic growth expectations.
A high dividend yield can sometimes be a value trap, indicating a stagnant or declining stock price rather than a healthy company. Managers may exit if the dividend appears unsustainable due to falling earnings or a high payout ratio, or if future dividend growth is projected to be minimal. Total return, which includes both price appreciation and dividends, is the ultimate goal, leading managers to sacrifice current yield for stronger future growth prospects.
Matrix's trade prioritizes US-centric earnings growth and dividend consistency over a higher but slower-growing yield from Europe.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.